| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 12.50 CAD | 0.01 (+0.08%) | 9.52 - 12.65 | -- |
Market data as of 12:00AM 05/24/13. Quotes are delayed by at least 15 min.
To provide long-term growth through capital appreciation. The Fund is managed to obtain a return that approximates the performance of the MSCI Europe Index. The MSCI Europe Index is a free float-adjusted market capitalization index that is designed to measure developed market equity performance in Europe. It consists of 16 countries in Europe.
| Total Return | 19.45% |
|---|---|
| Yield (Trailing 12 Mo.) | 4.01% |
| Expense Ratio | -- |
| Front Load | None |
| Deferred Load | None |
| Minimum Investment | $50,000 |
| Management Tenure | 8 Years |
| Fund Inception | 11/21/2011 |
| Timeframe | MUTUAL:CIB592 | S&P 500 | European Equity |
|---|---|---|---|
| 1 Month | 3.14% | 1.93% | 2.36% |
| 3 Month | 2.19% | 7.18% | 2.80% |
| Year-to-Date | 7.65% | 12.74% | 7.69% |
| 1 Year | 19.98% | 16.89% | 19.66% |
| 3 Year | -- | 12.80% | 7.25% |
| 5 Year | -- | 5.21% | -1.80% |
| 10 Year | -- | 7.88% | 4.81% |
| Since Inception | 19.45% | 10.38% | -- |
| Basic Materials | 9.21% | |
|---|---|---|
| Consumer Cyclical | 8.68% | |
| Financial Services | 18.89% | |
| Real Estate | 0.78% | |
| Consumer Defensive | 15.58% | |
| Healthcare | 13.04% | |
| Utilities | 3.81% | |
| Communication Services | 6.29% | |
| Energy | 9.58% | |
| Industrials | 10.13% | |
| Technology | 4.00% |
| By Percent | Short | 0% | Long | Net | |
|---|---|---|---|---|---|
| Stock | 0.00 | 0.00 | 0.00 | ||
| Bond | 0.00 | 0.00 | 0.00 | ||
| Other | 0.10 | 0.08 | -0.02 | ||
| Foreign Stock | 0.02 | 99.48 | 99.46 | ||
| Foreign Bond | 0.00 | 0.00 | 0.00 | ||
| Total | 0.12 | 99.56 | 99.44 | ||
| Cash | 0.00 | 0.55 | 0.55 | ||
| Total Net Assets | $46.26M |
|---|---|
| Total Stock Holdings | 446 |
| Total Bond Holdings | 0 |
| Company | YTD Return | % of Assets |
|---|---|---|
| Nestle SA | 9.65% | 2.87% |
| HSBC Holdings PLC | 4.07% | 2.55% |
| Roche Holding AG | 23.65% | 2.22% |
| Novartis AG | 17.50% | 2.17% |
| Vodafone Group PLC | 21.77% | 1.91% |
| BP PLC | 4.81% | 1.70% |
| Sanofi | -- | 1.66% |
| GlaxoSmithKline PLC | 20.09% | 1.55% |
| United Kingdom Ftse 100 Index Future, June 2013 | -- | 1.50% |
| Royal Dutch Shell PLC Class A | -0.16% | 1.50% |
| Valuation | MUTUAL:CIB592 | Category Range |
|---|---|---|
| Price/Earnings | 15.00 | |
| Price/Book | 1.57 | |
| Price/Sales | 0.93 | |
| Price/Cash Flow | 8.36 | |
| Dividend Yield | 3.19 | |
| LT Earnings | 8.72 | |
| Historical Earnings | 9.47 | |
| Sales Growth | -14.93 | |
| Cash-Flow Growth | -25.19 | |
| Book-Value Growth | 1.06 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
 |  |  |
| Rating | vs Category | |
|---|---|---|
| Overall | ||
| Risk | ||
| Return |
| Pretax Return | -- |
|---|---|
| Tax-adjusted Return | -- |
| Tax Cost Ratio | -- |
| Potential Cap Gains | -- |
